Kevin Kayser
Kevin Kayser is Senior Director, Head of Upstream R&D, at MilliporeSigma.
False
Advertisement
The Best Defense Is Good Science
December 13, 2017
Starting from fundamental virology, Kevin Kayser and the upstream R&D team at Merck discovered the mechanism by which Minute Virus of Mice (MVM) infects CHO cells, and the respective genes involved in viral uptake.
1 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
